How to Tackle Spring Allergies: Best Air Purifiers and Cleaners
The Shopping Trends team is independent of the journalists at CTV News. We may earn a commission when you use our links to shop. Read about us.
It's that time of year again: spring! Although the promise of warmer weather, longer days, and plants coming back to life is beautiful, for those who have allergies, it can be anything but. Dealing with allergy symptoms, especially if they're severe, can take the excitement for the season and really turn it on its head.
The good news is that there are plenty of ways to deal with seasonal allergies that will help you keep symptoms to a minimum so you can enjoy all the good spring brings without the bad. One of those interventions is throwing an air purifier into the mix because it filters out those pesky allergens that set symptoms in motion, so having one in your home can be a great way to limit your exposure. You also want to get cleaning products that will help to trap allergens without adding other irritants into your home.
To help you out, we've rounded up reviewer-favourite gadgets and cleaning supplies, saving you from surfing and scrolling (and sneezing). Here are a few of the best products for tackling spring allergies:
Disclaimer: The prices displayed are accurate at the time of publication. We'll do our best to keep them as up-to-date as possible, but you may see slight changes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
37 minutes ago
- Globe and Mail
Air Canada Foundation Releases 2024 Impact Report Highlighting Work Promoting Children's Health and Well-being
MONTRÉAL , June 16, 2025 /CNW/ - The Air Canada Foundation has released its 2024 Impact Report, showcasing programs and partnerships that have positively impacted children's lives across Canada . The report highlights key initiatives, charitable collaborations, humanitarian efforts, and the volunteer contributions of Air Canada employees. The Foundation empowers children through three core pillars: Health, by working with pediatric hospitals and community organizations to improve health outcomes of children and youth; Protection, by ensuring kids' fundamental needs are met and preserving the essence of childhood; and Dreams, by collaborating with groups that bring hope and strengthen resilience for children facing adversities. "The Air Canada Foundation remains committed to helping children and youth thrive. I extend my deepest gratitude to Air Canada's customers, partners, employees, retirees and volunteers whose steadfast support enables the Foundation to deliver hope, support and meaningful change where it's needed most," said Michael Rousseau , President and Chief Executive Officer at Air Canada. In 2024, the Foundation donated $1.8 million toward the well-being of communities — up 38 per cent from 2023. The Air Canada Foundation Golf Tournament raised a record-breaking $1.4 million (net). These funds are being strategically distributed to support children's health and well-being in Canada . The Hospital Transportation Program enabled 129 patients to access essential medical care with over 370 flights, while 400 airline tickets were donated to pediatric hospitals. Throughout the year, the Foundation helped combat food insecurity by providing around 900,000 meals to Breakfast Club Canada (BCC), Food Banks Canada and Second Harvest. The Foundation also responded in times of crisis through partnerships with humanitarian aid organizations and employee fundraising campaigns supporting relief efforts for hurricanes Beryl, Milton and Helene, as well as the Alberta wildfires and the Middle East humanitarian crisis. "I am proud to look back on another year of meaningful impact at the Air Canada Foundation — one defined by firm action, unwavering commitment and the power to adapt in the face of ever-changing challenges to better serve children and youth," said Priscille Leblanc , Chair of the Air Canada Foundation. Follow @fondation_aircanada_foundation on Instagram or visit to learn more about the Air Canada Foundation and the impact of its programs and charitable partnerships. About the Air Canada Foundation The Air Canada Foundation, a not-for-profit organization focused on the health and well-being of children and youth, was launched in 2012. It offers both financial and in-kind support to Canadian-registered charities. Core programs include the Hospital Transportation Program, which redistributes Aeroplan points to 15 pediatric hospitals across Canada , enabling sick children to access the medical care they need away from home. The Air Canada Foundation, in collaboration with the airline, also engages directly in fundraising activities, such as the Every Bit Counts program, which encourages customers to donate loose change of all denominations on board flights or through collection containers available in Air Canada Maple Leaf Lounges. The Foundation also offers continued support to major health-related causes that benefit Canadians and is an active participant in international humanitarian relief activity as the need arises. For more information about the Air Canada Foundation, please read the 2024 Impact Report. About Air Canada Air Canada is Canada's largest airline, the country's flag carrier and a founding member of Star Alliance , the world's most comprehensive air transportation network. Air Canada provides scheduled service directly to more than 180 airports in Canada , the United States and Internationally on six continents. It holds a Four-Star ranking from Skytrax. Air Canada's Aeroplan program is Canada's premier travel loyalty program, where members can earn or redeem points on the world's largest airline partner network of 45 airlines, plus through an extensive range of merchandise, hotel and car rental partners. Through Air Canada Vacations, it offers more travel choices than any other Canadian tour operator to hundreds of destinations worldwide, with a wide selection of hotels, flights, cruises, day tours, and car rentals. Its freight division, Air Canada Cargo, provides air freight lift and connectivity to hundreds of destinations across six continents using Air Canada's passenger and freighter aircraft. Air Canada's climate-related ambition includes a long-term aspirational goal of net-zero greenhouse gas emissions by 2050. For additional information, please see Air Canada's TCFD disclosure . Air Canada shares are publicly traded on the TSX in Canada and the OTCQX in the US. Sign up for Air Canada news: Media Resources: Photos Videos B-Roll Articles SOURCE Air Canada
CTV News
an hour ago
- CTV News
Ben Sweet plans to cycle across Canada in 11 days
Coldwater's Ben Sweet plans to cycle 5,800 kilometres across Canada in 11 days to raise funds for cancer research.
National Post
2 hours ago
- National Post
Satellos Bioscience to Participate in PPMD's Annual Conference in Las Vegas
Article content TORONTO — Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (' Satellos ' or the ' Company '), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced its participation in the 2025 Parent Project Muscular Dystrophy (PPMD) Annual Conference, taking place June 19–21 in Las Vegas, Nevada. Article content The PPMD Annual Conference brings together families, researchers, clinicians, and companies committed to improving outcomes for people living with Duchenne. Satellos will be onsite to engage with the Duchenne community, listen to families' experiences, and share updates on its science and mission to regenerate muscle from within. Article content Article content 'We're looking forward to connecting in person with families and advocates who are at the heart of this work,' said Frank Gleeson, Co-founder and CEO of Satellos. 'This conference is a powerful reminder of why we're focused on developing a new approach to treat Duchenne — one that aims to restore the body's ability to repair muscle.' Article content Attendees can meet members of the Satellos team throughout the event and learn more by visiting the company's booth in the exhibition hall. Article content About Satellos Bioscience Inc. Article content Satellos is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, Satellos has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that Satellos has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. By restoring this missing dystrophin signal in DMD, SAT-3247 enables muscle stem cells to divide properly and more efficiently, promoting natural muscle repair and regeneration. SAT-3247 is currently in clinical development as a potential disease-modifying treatment initially for DMD. Satellos also is leveraging its proprietary discovery platform MyoReGenX™ to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. For more information, visit Article content This press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Satellos and its business, which may include, but are not limited to, statements regarding the potential for SAT-3247 to represent a disease modifying approach to the therapeutic treatment of people living with Duchenne; anticipated benefits to patients from a small molecule treatment for Duchenne; the advancement SAT-3247 through clinical trials; the pharmacodynamic properties and mechanism-of-action of SAT-3247; the potential of our approach in other degenerative muscle diseases; its/their prospective impact on Duchenne patients, patients with other degenerative muscle disease or muscle injury or trauma, and on muscle regeneration generally; and Satellos' technologies and drug development plans. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, occurrences or developments, are 'forward-looking information or statements.' Often but not always, forward-looking information or statements can be identified by the use of words such as 'shall', 'intends', 'believe', 'plan', 'expect', 'intend', 'estimate', 'anticipate', 'potential', 'prospective' , 'assert' or any variations (including negative or plural variations) of such words and phrases, or state that certain actions, events or results 'may', 'might', 'can', 'could', 'would' or 'will' be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, risks relating to the pharmaceutical and bioscience industry (including the risks associated with preclinical and clinical trials and regulatory approvals), and the research and development of therapeutics, the results of preclinical and clinical trials, general market conditions and equity markets, economic factors and management's ability to manage and to operate the business of the Company generally, including inflation and the costs of operating a biopharma business, and those risks listed in the 'Risk Factors' section of Satellos' Annual Information Form dated March 26, 2025 (which is located on Satellos' profile at Although Satellos has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Satellos does not undertake any obligation to publicly update or revise any forward-looking statement, whether resulting from new information, future events, or otherwise. Article content Article content Article content Article content Article content Contacts Article content Investors: Article content Liz Williams, CFO, Article content ir@ Article content Article content Media: Article content Emily Williams, Senior Director, Communications, Article content Article content Article content
